An observational study in Noninvasive Ventilation, Nutrition Therapy and Respiratory Insufficiency, sponsored by Università degli Studi del Piemonte Orientale Amedeo Avogadro. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-13.
Sponsored by Università degli Studi del Piemonte Orientale Amedeo Avogadro · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 112 studies in Respiratory Insufficiency with a site in Italy — 27 open to participants now, 28 under way, 2 of them phase 3. Respiratory Insufficiency · Italy.
Among the 112 studies in Respiratory Insufficiency with a site in Italy, this one is the 19th largest by enrollment of the 45 observational ones that give a count, is one of 12 that started in 2024, is one of 45 observational ones, and was the 95th registered.
1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.
Browse Respiratory Insufficiency studies →27 of the 112 studies in Respiratory Insufficiency with a site in Italy are open now. Recruiting first, the newest first:
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Sites in Italy
Ages 18+
Istituto Clinico Humanitas · Sites in Italy
Ages 18+
Centre for Medical Sciences · Sites in Italy
Ages 18+
Università Vita-Salute San Raffaele · Sites in Italy
Ages 65+ · Healthy volunteers
Istituto Giannina Gaslini · Sites in Italy
Ages 18+ · Men only
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
112 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 12 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 112 is above the median of 100 across 456 observational studies indexed under Respiratory Insufficiency.
Median enrollment 55 across the 65 interventional studies, 93 across the 45 observational. Of the 65 that completed or were terminated, 4 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 112 have an industry lead sponsor. The 10 most frequent:
Università degli Studi del Piemonte Orientale Amedeo Avogadro is the lead sponsor of 15 studies on the registry; 3 are open to participants now.
Università degli Studi del Piemonte Orientale Amedeo Avogadro has 1 study filed under Respiratory Insufficiency — fewer than ten, so there is no comparison to draw.
7 of the studies in Respiratory Insufficiency with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07098611Medipol UniversityA New Tool for Extubation Readiness in Mechanically Ventilated Patients: Readiness for EXtubation Score | 2026-12-30 |
| NCT06511583Azienda Ospedaliero-Universitaria CareggiFBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency Department | 2027-02-05 |
| NCT07175194Istituto Clinico HumanitasAssociation Between EIT and CT During PEEP Titration in Patients With Acute Respiratory Failure | 2027-03 |
| NCT05440851University Health Network, TorontoPlatform of Randomized Adaptive Clinical Trials in Critical Illness | 2027-03-31 |
| NCT06001645Università Vita-Salute San RaffaeleLaboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS) | 2027-04 |
Add all 7 to your calendar (.ics) → With an account.
Among the 112 studies in Respiratory Insufficiency with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Even though nutrition is a fundamental component of Intensive care unit (ICU) therapy, critically ill patients are frequently malnourished, a factor well known for its strong association with a higher risk of complications, prolonged ICU/hospital length of stay, and greater ICU readmission and mortality rates. Noninvasive ventilation (NIV) use has increased considerably over the past twenty years, making this supportive technique a keystone of acute respiratory failure (ARF) treatment. In this setting, respiratory support is provided through an interface, usually a mask or a helmet, that frequently represents an important obstacle to nutrition delivery, making oral intake impossible and posing the necessity to start enteral (EN) or parenteral nutrition (PN). Moreover, while critical care guidelines regarding nutritional management of patients receiving mechanical ventilation (MV) are well established, data and recommendations about the appropriate nutritional support to patients in NIV are still very limited. Due to this limited data, we want to describe characteristics and nutritional management of patients undergoing NIV in ICU, and to evaluate the difference between the mean caloric and protein intake of these patients and the recommended caloric and protein target for critically ill patients. Secondarily, we want to evaluate the difference of the caloric and protein intake among groups of patients undergoing different nutritional modality and to assess potential associations of the nutritional characteristics with patient outcomes.
Adult patients admitted to the Intensive Care Unit of Maggiore della Carità University Hospital from March 1st 2020 to February 28th 2023, undergoing noninvasive ventilation for any diagnosis of acute respiratory failure and for any cause (to avoid endotracheal intubation, as alternative to invasive ventilation, as weaning from invasive ventilation) will be considered.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Caloric and protein gap
to evaluate the difference between the mean caloric and protein intake of these patients and the recommended caloric and protein target for critically ill patients for every day of ICU stay
Time frame: At ICU discharge, a median of six days
Nutrition modalities outcomes
to evaluate the difference of the mean caloric and protein intake among groups of patients undergoing different nutritional modality
Time frame: At ICU discharge, a median of six days
Ran from Mar 2024 to primary completion in May 2024, 2 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Università degli Studi del Piemonte Orientale Amedeo Avogadro